Bepridil--a new antianginal agent with antiarrhythmic properties
Laskawiec, G.; Zmudziński, J.; Jamrozik-Kruk, Z.
Polski Tygodnik Lekarski 48(14-15): 330-332
1993
ISSN/ISBN: 0032-3756 PMID: 8415249 Document Number: 415585
Document emailed within 1 workday
Related Documents
Lynch, J.J.; Montgomery, D.G.; Ventura, A.; Lucchesi, B.R. 1985: Antiarrhythmic and electrophysiologic effects of bepridil in chronically infarcted conscious dogs Journal of Pharmacology and Experimental Therapeutics 234(1): 72-80Ernest, K. 1975: Pharmacology of new ethylenediamine derivatives (ROM-126, ROM-131, MK-142) with antiarrhythmic action. Part II. Antiarrhythmic properties, the influence on heart and some hemodynamic parameters Polish Journal of Pharmacology and Pharmacy 27(4): 381-398
Stern, Z.; Levy, M. 1981: Nifedipine--a new antianginal agent Harefuah 100(10): 494-496
Tsuboi, T.; Hatano, N.; Nakatsuji, K.; Fujitani, B.; Yoshida, K.; Shimizu, M.; Kawasaki, A.; Sakata, M.; Tsuboshima, M. 1980: Pharmacological evaluation of OP 1206, a prostaglandin E1 derivative, as an antianginal agent Archives Internationales de Pharmacodynamie et de Therapie 247(1): 89-102
Demchenko, E.A.; Berezina, A.V.; Panov, A.V. 2002: Antianginal and anti-ischemic effects of Mono Mac 50D preparation as an agent in combined treatment of patients with stable angina Klinicheskaia Meditsina 80(9): 57-59
Sloskey, G.E. 1983: Amiodarone: a unique antiarrhythmic agent Clinical Pharmacy 2(4): 330-340
Borkowski, P.J. 1970: Bretylium tosylate as an antiarrhythmic agent Kardiologia Polska 13(2): 195-198
Kozák, P.; Stárek, A.; Hes, I.; Spacek, R. 1985: Propafenone--a new antiarrhythmic agent. Clinical experience Casopis Lekaru Ceskych 124(13): 407-410
Gülker, H.; Thale, J.; Olbing, B.; Heuer, H.; Frenking, B.; Bender, F. 1985: Assessment of the antiarrhythmic profile of the new class i agent diprafenone Arzneimittel-Forschung 35(9): 1387-1393
Dvorák, K.; Vavros, B.; Cerný, J. 1975: Bretylium tosylate--a new antiarrhythmic agent with antifibrillatory effect Vnitrni Lekarstvi 21(3): 278-284
Lindstrom, T.D.; Lacefield, W.B.; Whitaker, G.W. 1984: Metabolism of the antiarrhythmic agent, indecainide, in rats, dogs, and monkeys Drug Metabolism and Disposition: the Biological Fate of Chemicals 12(6): 691-697
Karapetian, A.E.; Gevorkian, R.A. 1972: Action of 4-methyluracil as an antiarrhythmic agent stimulating the growth of myocardial cells Farmakologiia i Toksikologiia 35(3): 297-299
Corday, E.; Enescu, V.; Vyden, J.K.; Serruya, A.; Lang, T.W.; Carvalho, M. 1971: Antiarrhythmic properties of carbamazepine Geriatrics 26(10): 78-81
Rivera-Bou, W.L.; Torres-Galarza, F.; Deynes, S. 2007: Can etomidate have antiarrhythmic properties? Boletin de la Asociacion Medica de Puerto Rico 99(4): 310-313
Valkó, I.; Szepesi, G. 1990: An improved TLC method for investigation of the metabolic profile of BGYKI-38233--a new antiarrhythmic agent Die Pharmazie 45(4): 290
Cheng, Y.N.; Kiyosue, T.; Arita, M. 1994: Effects of KT-362, a new antiarrhythmic agent, on membrane ionic currents of guinea pig ventricular myocytes Journal of Pharmacology and Experimental Therapeutics 270(3): 851-857
Beck, O.A.; Witt, E.; Hochrein, H. 1975: Effect of the antiarrhythmic agent propaphenone on cardiac conduction. clinical studies using bundle of his electrography Zeitschrift für Kardiologie 64(2): 179-187
Eckstein, M.; Zajaczkowska, J.; Samochowiec, L. 1988: (RS), (R)(-) and (S)(+) derivatives of 2-N-arylalkylamino-1-butanol having antiarrhythmic properties Polish Journal of Pharmacology and Pharmacy 40(4): 401-411
Reymond, C.; Rivier, J.L. 1973: Clinical study of the antiarrhythmic properties of amiodarone Therapeutische Umschau. Revue Therapeutique 30(3): 223-230
Fiset, C.; Drolet, B.; Hamelin, B.A.; Turgeon, J. 1997: Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class IIi antiarrhythmic drug dl-sotalol Journal of Pharmacology and Experimental Therapeutics 283(1): 148-156